MYnd Analytics Inc (NASDAQ:MYND) Director John Pappajohn acquired 10,000 shares of the firm’s stock in a transaction that occurred on Friday, January 5th. The stock was bought at an average price of $3.44 per share, with a total value of $34,400.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Shares of MYnd Analytics Inc (MYND) opened at $3.57 on Tuesday. MYnd Analytics Inc has a 1-year low of $2.80 and a 1-year high of $9.00.
Separately, Maxim Group set a $18.00 price objective on MYnd Analytics and gave the company a “buy” rating in a report on Thursday, January 4th.
MYnd Analytics Company Profile
MYnd Analytics, Inc, formerly CNS Response, Inc, is a predictive analytics company. The Company has developed a decision support tool to help physicians reduce trial and error treatment in mental health, and provide personalized care to patients. The Company provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post-traumatic stress disorder (PTSD) and other non-psychotic disorders.
Receive News & Ratings for MYnd Analytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYnd Analytics and related companies with MarketBeat.com's FREE daily email newsletter.